文献速递浆细胞疾病淋巴瘤

活化B细胞中miR-15a/16-1缺失促进浆细胞及成熟B细胞肿瘤发生

miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasms.
PubMed 文献 · Blood · 2021-01-01

研究通过条件性敲除小鼠生发中心B细胞的miR-15a/16-1簇,发现其诱导生发中心B细胞增多、暗区比例升高及浆细胞分化,随时间发生类似人类髓外浆细胞瘤及滤泡性/弥漫大B细胞淋巴瘤的成熟B细胞肿瘤。人类原发髓外浆细胞瘤中miR-15a/16低表达且del(13q)为最常见遗传缺失,其突变谱与多发性骨髓瘤相似但超二倍体频率低。

要点

  • miR-15a/16-1缺失在生发中心B细胞中引发广泛分子和功能改变并促肿瘤发生。
  • 小鼠模型再现人类原发髓外浆细胞瘤的惰性及无骨髓侵犯特征。
  • 人类原发髓外浆细胞瘤miR-15a/16低表达且del(13q)常见,超二倍体频率低。

核心结论

  • miR-15a/16-1簇在生发中心反应调控中起重要作用,并在浆细胞和B细胞恶性肿瘤中具有依赖背景的抑癌功能。

研究设计与样本

  • 研究采用小鼠生发中心B细胞条件性敲除miR-15a/16-1簇的体内模型,并分析人类原发髓外浆细胞瘤样本。

主要发现

  • 条件性敲除miR-15a/16-1簇导致生发中心B细胞数量增加、暗区B细胞比例升高及浆细胞成熟增多。
  • 随时间推移,小鼠发生类似人类髓外浆细胞瘤、滤泡性淋巴瘤和弥漫大B细胞淋巴瘤的成熟B细胞肿瘤。
  • 小鼠髓外浆细胞瘤呈惰性且无骨髓侵犯,类似人类原发髓外浆细胞瘤而非进展期多发性骨髓瘤的髓外病变。
  • 人类原发髓外浆细胞瘤中miR-15a/16表达低,del(13q)为最常见遗传缺失。
  • 人类原发髓外浆细胞瘤突变谱与多发性骨髓瘤相似,但超二倍体频率低。

临床怎么用

  • 提示miR-15a/16-1缺失参与生发中心B细胞来源的浆细胞和B细胞肿瘤起始,可作为机制解释和潜在研究方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chromosome 13q deletion [del(13q)], harboring the miR-15a/16-1 cluster, is one of the most common genetic alterations in mature B-cell malignancies, which originate from germinal center (GC) and post-GC B cells. Moreover, miR-15a/16 expression is frequently reduced in lymphoma and multiple myeloma (MM) cells without del(13q), suggesting important tumor-suppressor activity. However, the role of miR-15a/16-1 in B-cell activation and initiation of mature B-cell neoplasms remains to be determined. We show that conditional deletion of the miR-15a/16-1 cluster in murine GC B cells induces moderate but widespread molecular and functional changes including an increased number of GC B cells, percentage of dark zone B cells, and maturation into plasma cells. With time, this leads to development of mature B-cell neoplasms resembling human extramedullary plasmacytoma (EP) as well as follicular and diffuse large B-cell lymphomas. The indolent nature and lack of bone marrow involvement of EP in our murine model resembles human primary EP rather than MM that has progressed to extramedullary disease. We corroborate human primary EP having low levels of miR-15a/16 expression, with del(13q) being the most common genetic loss. Additionally, we show that, although the mutational profile of human EP is similar to MM, there are some exceptions such as the low frequency of hyperdiploidy in EP, which could account for different disease presentation. Taken together, our studies highlight the significant role of the miR-15a/16-1 cluster in the regulation of the GC reaction and its fundamental context-dependent tumor-suppression function in plasma cell and B-cell malignancies.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Sewastianik T, Straubhaar JR, Zhao JJ, et al. miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasms. Blood. 2021. PMID: 33751108. doi:10.1182/blood.2020009088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。